Global Health Solutions, Inc Sample Contracts
POSTING AGREEMENTPosting Agreement • January 31st, 2025 • Global Health Solutions, Inc • California
Global Health Solutions Inc (DBA Turn Therapeutics) [COMPANY], a Delaware [STATE] C Corp [ENTITY] located at 250 N Westlake Blvd, Westlake Village, CA [ADDRESS] (the “Company”), proposes, subject to the terms and conditions contained in this Posting Agreement (this “Agreement”), to issue and sell shares of its Common Stock [SECURITIES], $___ par value per share (the “Shares”) to investors (collectively, the “Investors”) in a public offering (the “Offering”) on the online website provided by StartEngine Crowdfunding, Inc. (the “Platform”) pursuant to Regulation A through StartEngine Primary LLC ( “StartEngine”), acting on a best efforts basis only, in connection with such sales. The Shares are more fully described in the Offering Statement (as hereinafter defined).
Escrow Agreement FOR SECURITIES OFFERINGEscrow Agreement • January 31st, 2025 • Global Health Solutions, Inc • Delaware
This Escrow Agreement, effective as of 01/19/2025, (“Escrow Agreement”), is by, between and among The Bryn Mawr Trust Company of Delaware, a Delaware Limited Purpose Trust Company and located at 20 Montchanin Rd., Suite 100, Greenville, DE 19807 as Escrow Agent hereunder (“Escrow Agent”); StartEngine Primary LLC (“Broker”), a Delaware Limited Liability Company, located at 4100 W. Alameda Ave, 3rd floor Burbank, CA 91505 ; and Global Health Solutions Inc., a Delaware(“Issuer”) located at 250 North Westlake Blvd. #210, Westlake Village, CA 91362.
REGISTRATION RIGHTS AGREEMENT December 7, 2024Registration Rights Agreement • January 31st, 2025 • Global Health Solutions, Inc
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into as of the date first above written, by and among GLOBAL HEALTH SOLUTIONS, INC. (D/B/A TURN THERAPEUTICS), a corporation incorporated under the laws of Delaware whose registered office is at 250 North Westlake Blvd. #210, Westlake Village, CA 91362 (the “Company”), GEM GLOBAL YIELD LLC SCS, a “société en commandite simple” formed under the laws of Luxembourg having LEI No. 213800CXBEHFXVLBZO92 having an address at 12C, rue Guillaume J. Kroll, L-1882 Luxembourg (the “Purchaser”); and GEM YIELD BAHAMAS LIMITED, a limited company formed under the laws of the Commonwealth of the Bahamas and having an address at 3 Bayside Executive Park, West Bay Street & Blake Road, P.O. Box N-4875, Nassau, The Bahamas (“GYBL,” and together with the Company and Purchaser, the “Parties”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement (as defin
SHARE PURCHASE AGREEMENT dated as of December 7, 2024 by and among GLOBAL HEALTH SOLUTIONS, INC. (D/B/A TURN THERAPEUTICS), GEM GLOBAL YIELD LLC SCS and GEM YIELD BAHAMAS LIMITEDShare Purchase Agreement • January 31st, 2025 • Global Health Solutions, Inc • New York
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • March 26th, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • Delaware
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 16th, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of , 2025, is by and between Turn Therapeutics, Inc., a Delaware limited liability company (the “Company”), and Zuraiz Chaudhary (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 2nd, 2025 • Turn Therapeutics Inc. • Pharmaceutical preparations
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 15, 2025, is by and between Turn Therapeutics, Inc., a Delaware limited liability company (the “Company”), and Bradley E. Burnam (the “Executive”).
SUBSCRIPTION AGREEMENTSubscription Agreement • March 27th, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • Delaware
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
STOCKHOLDERS AGREEMENTStockholders Agreement • September 2nd, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • Delaware
AGREEMENT, dated as of [•], 2025 (“Agreement”) among the parties listed on the signature pages hereto (each, together with his, her or its Permitted Transferees (as defined below), a “Holder,” and together, the “Holders”) and Turn Therapeutics Inc. (the “Company”).
FORM OF REGISTRATION RIGHTS AGREEMENT by and among TURN THERAPEUTICS INC. and THE STOCKHOLDERS IDENTIFIED ON THE SIGNATURE PAGE HERETO Dated as of [●], 2025Registration Rights Agreement • September 2nd, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT, dated as of [●] (this “Agreement”), is by and among Turn Therapeutics Inc., a Delaware corporation (the “Company”) and certain stockholders of the Company identified on the signature page hereto (each, a “Holder” and collectively, the “Holders”).
LOAN AND SECURITY AGREEMENT Dated as of March 23, 2026 among TURN THERAPEUTICS INC., a Delaware corporation, (“Turn Therapeutics”), TURN CONSUMER LLC, a Delaware limited liability company (“Turn Consumer”; and together with Turn Therapeutics, jointly...Loan and Security Agreement • March 24th, 2026 • Turn Therapeutics Inc. • Pharmaceutical preparations • California
Borrower, Lenders and Agent have entered or anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties (collectively referred to as this “Agreement”).
PLATFORM INTELLECTUAL PROPERTY LICENSE AGREEMENTPlatform Intellectual Property License Agreement • September 2nd, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • Delaware
THIS PLATFORM INTELLECTUAL PROPERTY LICENSE (the “Agreement”), effective as of the 30th day of November 2022 (the “Effective Date”), is made by and between Global Health Solutions, Inc. (d.b.a. Turn Therapeutics), a Delaware corporation, with its principal offices at 250 N Westlake Blvd, Suite 210, Westlake Village, CA 91362 (“Turn”), and MiMedx Group, Inc., a Florida corporation, with its principal offices at 1775 West Oak Commons Court, NE, Marietta, GA 30062 (“MIMEDX”). MIMEDX and Turn are sometimes referred to herein, individually, as a “Party” or, collectively, as the “Parties.”
Side Letter to Purchase Agreement September 24, 2025Side Letter to Purchase Agreement • September 24th, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations
This side letter (this “Letter”) constitutes the agreement of the Parties that the Purchase Agreement shall be amended and/or supplemented by the following provisions, so that this Letter shall form an integral part of the Purchase Agreement and the provisions of the Purchase Agreement shall apply accordingly. Except as set forth herein, the provisions of the Purchase Agreement are not amended and remain in full force and effect.
REGISTRATION RIGHTS AGREEMENT by and among TURN THERAPEUTICS INC. and THE STOCKHOLDERS IDENTIFIED ON THE SIGNATURE PAGE HERETO Dated as of September 11, 2025Registration Rights Agreement • October 2nd, 2025 • Turn Therapeutics Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT, dated as of September 11, 2025 (this “Agreement”), is by and among Turn Therapeutics Inc., a Delaware corporation (the “Company”) and certain stockholders of the Company identified on the signature page hereto (each, a “Holder” and collectively, the “Holders”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT August 29, 2025Registration Rights Agreement • September 2nd, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations
This AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into as of the date first above written, by and among GLOBAL HEALTH SOLUTIONS, INC. (D/B/A TURN THERAPEUTICS), a corporation incorporated under the laws of Delaware whose registered office is at 250 North Westlake Blvd. #210, Westlake Village, CA 91362 (the “Company”), GEM GLOBAL YIELD LLC SCS, a “société en commandite simple” formed under the laws of Luxembourg having LEI No. 213800CXBEHFXVLBZO92 having an address at 12C, rue Guillaume J. Kroll, L-1882 Luxembourg (the “Purchaser”); and GEM YIELD BAHAMAS LIMITED, a limited company formed under the laws of the Commonwealth of the Bahamas and having an address at 3 Bayside Executive Park, West Bay Street & Blake Road, P.O. Box N-4875, Nassau, The Bahamas (“GYBL,” and together with the Company and Purchaser, the “Parties”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchas
AMENDED AND RESTATED SHARE PURCHASE AGREEMENT dated as of August 29, 2025 by and among GLOBAL HEALTH SOLUTIONS, INC. (D/B/A TURN THERAPEUTICS), GEM GLOBAL YIELD LLC SCS and GEM YIELD BAHAMAS LIMITED Article 1 DEFINITIONSShare Purchase Agreement • September 2nd, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations • New York
This AMENDED AND RESTATED SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of the date first above written by and among GLOBAL HEALTH SOLUTIONS, INC. (D/B/A TURN THERAPEUTICS), a corporation incorporated under the laws of Delaware whose registered office is at 250 North Westlake Blvd. #210, Westlake Village, CA 91362 (the “Company”); GEM GLOBAL YIELD LLC SCS, a “société en commandite simple” formed under the laws of Luxembourg having LEI No. 213800CXBEHFXVLBZO92 having an address at 12C, rue Guillaume J. Kroll, L-1882 Luxembourg (the “Purchaser”); and GEM YIELD BAHAMAS LIMITED, a limited company formed under the laws of the Commonwealth of the Bahamas and having an address at 3 Bayside Executive Park, West Bay Street & Blake Road, P.O. Box N-4875, Nassau, The Bahamas (“GYBL,” and together with the Company and Purchaser, the “Parties”).
CERTAIN INFORMATION IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. MATERIAL SUPPLY AND DEVELOPMENT AGREEMENTMaterial Supply and Development Agreement • October 28th, 2025 • Turn Therapeutics Inc. • Pharmaceutical preparations • Illinois
This Material Supply and Development Agreement (“Agreement”), effective on October 23, 2025 (the “Effective Date”), is between Medline Industries, LP, an Illinois limited partnership with its principal offices located at 3 Lakes Drive, Northfield, IL 60093 together with any affiliates who place orders pursuant to this Agreement (collectively, “Medline”), and Turn Therapeutics Inc. with offices at 250 North Westlake Blvd., #210, Westlake Village, CA 91362 (the “Supplier” and, together with Medline, the “Parties” and each a “Party”). This Agreement supersedes all other existing distribution, supply, or corporate program agreements between Supplier and Medline.
STOCKHOLDERS AGREEMENTStockholders Agreement • October 2nd, 2025 • Turn Therapeutics Inc. • Pharmaceutical preparations • Delaware
AGREEMENT, dated as of September 11, 2025 (“Agreement”) among the parties listed on the signature pages hereto (each, together with his, her or its Permitted Transferees (as defined below), a “Holder,” and together, the “Holders”) and Turn Therapeutics Inc. (the “Company”).
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Loan and Security Agreement • March 24th, 2026 • Turn Therapeutics Inc. • Pharmaceutical preparations
This is a Supplement identified in the document entitled Loan and Security Agreement, dated as of March 23, 2026 (as amended, restated, supplemented and modified from time to time, the “Loan and Security Agreement”), by and among Borrower, Lenders and Agent. All capitalized terms used in this Supplement and not otherwise defined in this Supplement have the meanings ascribed to them in Article 10 of the Loan and Security Agreement, which is incorporated in its entirety into this Supplement. In the event of any inconsistency between the provisions of the Loan and Security Agreement and this Supplement, this Supplement is controlling.
EXPLANATORY NOTESubscription Agreement • March 26th, 2025 • Global Health Solutions, Inc • Pharmaceutical preparations
Global Health Solutions, Inc., has prepared this Form 1-A/A solely for the purpose of refiling the Subscription Agreement (Exhibit 4), to change the number of shares being offered in this offering.